Cite Filings / GANX
Feed Companies Filings Check
Sign in

CIK 0001819411

  • Emerging growth company

Gain Therapeutics, Inc.

Sign in to watch
Ticker
GANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851726310
Phone
+1 301-500-1556
Business address
4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
Filings Financials Insiders Search text
All 243 Financials 93 Shareholder Meetings 6 Executive Compensation 80 Insider Trading 82 Beneficial Ownership Interest 6 Business Combinations 69 Public Offerings 35 Mutual Funds and ETFs 5 Others 26
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-28
  3. DEF 14A Proxy Proxy Statement 2025-04-29
  4. DEF 14A Proxy Proxy Statement 2024-04-26
  5. DEF 14A Proxy Proxy Statement 2023-04-28
  6. DEF 14A Proxy Proxy Statement 2022-05-13
  7. SC 13G/A Stake Amended Statement of Ownership 2021-03-29

Page 1 of 1 · 6 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…